NeutriSci and Pacwest Announce Technology and IP Arrangement for R&D Product Development

Author's Avatar
May 25, 2021

VANCOUVER, BC / ACCESSWIRE / May 25, 2021 / NeutriSci International Inc. ("NeutriSci" or the "Company") (TSXV:NU, Financial)(OTCQB:NRXCF)(FRA:1N9, Financial), an innovative technology company developing products, licencing IP and technology for B2B partnerships and the nutraceutical industry, is pleased to announce the completion of an arrangement with its manufacturing partner, Pacwest Manufacturing Group Inc. ("Pacwest"), to provide the use of its NeutriSci's IP and technology to assist Pacwest's development of several new product lines which will also include Delta 8 ("D8"), a psychoactive cannabinoid found in the cannabis plant.